Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solvent-free dehydration method for bis-(5-formylfurfuryl) ether. High purity, low catalyst usage, scalable for pharmaceutical and fine chemical supply chains.
Patent CN114920640A details a novel TBADT-catalyzed [3+2] cycloaddition for aromatic sesquiterpenes, offering significant cost reduction and supply chain reliability.
Novel FeCl3-catalyzed route for polysubstituted N-arylpyrroles. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for scalable production.
Novel asymmetric catalytic synthesis method for Finerenone intermediates offering high purity and scalable production capabilities for global pharmaceutical supply chains.
Patent CN107056849A details mild I2-Et3SiH catalysis for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Patent CN101429199B details a mild two-step racemization process for fluoroquinolone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111116531A reveals a novel one-step hydrogenation method for Ramelteon intermediates, offering superior purity and safer processing for pharmaceutical manufacturing.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Advanced preparation of Maropitant intermediates via transition metal catalysis. High purity, >99% ee, and scalable routes for pharmaceutical manufacturing.
Patent CN101289441A details a cost-effective urea-based synthesis for Carisoprodol. This method offers significant supply chain advantages and reduced manufacturing costs for API producers.
Patent CN106423281A reveals a novel rare earth silamide catalyst for efficient spiro[cyclopropane-1,3'-indole] synthesis, offering mild conditions and cost reduction.
Novel rare earth silamide catalyzed one-pot synthesis for high-purity spiro[cyclopropane-1,3'-indole] intermediates. Cost-effective and scalable pharma manufacturing.
Patent CN110878064A reveals a breakthrough synthesis route for febuxostat impurities, boosting total yield from 0.2% to 43% via strategic intermediate sequencing.
Patent CN110862363B reveals a green route for furanylaldehydes using heterogeneous Mn catalysts, offering high selectivity and cost reduction for pharma intermediates.
Advanced four-step synthesis route for Sacubitril intermediates offering high purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN116120325B reveals a novel preparation method for Ketorolac EP Impurity D with high purity and simplified operations for reliable pharmaceutical intermediates supply chains.
Patent CN115417819B reveals improved synthesis using mesoporous MCM-41 ensuring high purity stability and supply chain cost advantages.
Novel dibromo-amino silica gel method achieves >99% selectivity and >99.8% purity for SGLT-2 inhibitors, significantly reducing waste and manufacturing costs.
Patent CN110483475A reveals mild silver oxide catalysis for benzothiophenes ensuring high yield and cost reduction for supply chains.
Patented chloroform-based route for o-chloromandelic acid ensures high purity and cost reduction in API intermediate manufacturing for global supply chains.